Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| BXLT Historical Stock Prices |
| Preferred Stock Newsletter |
| BXLT Options Chain |
| Stock Message Boards |
BXLT (BXLT) has the following price history information. Looking back at BXLT historical stock prices for the last five trading days, on February 28, 2017, BXLT opened at $46.02, traded as high as $46.02 and as low as $46.02, and closed at $46.02. Trading volume was a total of 0 shares. On March 01, 2017, BXLT opened at $46.02, traded as high as $46.02 and as low as $46.02, and closed at $46.02. Trading volume was a total of 0 shares. On September 11, 2017, BXLT opened at $0.00, traded as high as $0.00 and as low as $0.00, and closed at $45.95. Trading volume was a total of 0 shares. On September 12, 2017, BXLT opened at $0.00, traded as high as $0.00 and as low as $0.00, and closed at $45.95. Trading volume was a total of 0 shares. On November 28, 2017, BXLT opened at $0.00, traded as high as $0.00 and as low as $0.00, and closed at $45.95. Trading volume was a total of 0 shares.
BXLT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into BXLT shares, starting with a $10,000 purchase of BXLT, and working forward through the historical stock price information to today. No data found
 | |||||
| BXLT Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 02/28/2017 | $46.02 | $46.02 | $46.02 | $46.02 | 0 |
| 03/01/2017 | $46.02 | $46.02 | $46.02 | $46.02 | 0 |
| 09/11/2017 | $0.00 | $0.00 | $0.00 | $45.95 | 0 |
| 09/12/2017 | $0.00 | $0.00 | $0.00 | $45.95 | 0 |
| 11/28/2017 | $0.00 | $0.00 | $0.00 | $45.95 | 0 |
|
| About BXLT |
| Baxalta develops, manufactures and markets a diverse portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions. Co. is also investing in new disease areas, including oncology, as well as emerging technology platforms, including gene therapy and biosimilars. Co.'s business consists of a portfolio of products serving patient needs in a variety of ways. Co.'s four groups consist of Hemophilia, Inhibitor Therapies, Immunoglobulin Therapies and BioTherapeutics. |
| BXLT Historical Closing Prices | |
| Date | Close |
| 02/28/2017 | $46.02 |
| 03/01/2017 | $46.02 |
| 09/11/2017 | $45.95 |
| 09/12/2017 | $45.95 |
| 11/28/2017 | $45.95 |
| Healthcare Historical Prices |
| BXLT is categorized under the Healthcare sector; below are some other companies in the same sector:
CADX Historical Stock Prices
|
Free BXLT Email Alerts:
BXLT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.